Section one: Contracting authority
one.1) Name and addresses
National Institute For Health And Care Excellence
Level 1 City Tower
Manchester
M14BT
Contact
Irene Walker
Telephone
+44 1618703198
Country
United Kingdom
NUTS code
UKD - North West (England)
Internet address(es)
Main address
Buyer's address
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
https://www.gov.uk/contracts-finder
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted to the following address:
National Institute for Health and Care Excellence
Level 1 City Tower
Manchester
M14BT
Contact
Irene Walker
Country
United Kingdom
NUTS code
UKD3 - Greater Manchester
Internet address(es)
Main address
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
External Assessment Centres Framework
Reference number
NICEEACF22
two.1.2) Main CPV code
- 73000000 - Research and development services and related consultancy services
two.1.3) Type of contract
Services
two.1.4) Short description
NICE is seeking to commission external assessment centres (EACs) which will provide a range of health technology assessment (HTA) services to support its technology evaluation programmes and related activities (see above). Suppliers must be able to provide all services within Lots 1 and 2, for Lot 3, 3a or 3b to bid for that Lot. Suppliers need to be able to provide only the services within a work package to bid for any of the work packages within Lot 4.
Suppliers can bid for one or more Lots.
NICE will consider bids from multidisciplinary centres with knowledge and expertise in health technology assessment, enhanced for Lots 1 and 3 by a close association with frontline clinical services in areas related to medical technologies such as imaging or in vitro diagnostics.
Suppliers intending to provide services in Lot 2 will have significant expertise and experience of advanced HTA methods and be able to provide the service in relation to pharmaceuticals, medical, digital and diagnostic technologies.
NICE will consider proposals from consortia or networks of organisations meeting the selection criteria and encourages potential suppliers to explore collaborations that will result in the offer of a comprehensive range of services.
two.1.5) Estimated total value
Value excluding VAT: £5,884,000
two.1.6) Information about lots
This contract is divided into lots: Yes
Tenders may be submitted for all lots
two.2) Description
two.2.1) Title
Clinical and Economic Evidence Assessment
Lot No
1
two.2.2) Additional CPV code(s)
- 73000000 - Research and development services and related consultancy services
two.2.3) Place of performance
NUTS codes
- UKD - North West (England)
two.2.4) Description of the procurement
Including: critical appraisal of submitted evidence to support the development of NICE outputs; evidence synthesis; de novo economic modelling and critiquing and revising existing models; updating information and evidence on technologies to support guidance review; preparation of evidence summaries on new and novel technologies; systematic review and meta-analysis; market intelligence analysis; supporting identification, topic selection and scoping of medtech products, confirmations of regulatory status for medtech products.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
33
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
Options to extend for 1 x 15 months period
two.2.14) Additional information
NICE has had numerous technical issues issuing the notice onto Find a Tender. The notice was published on Contracts Finder on the 15th November 2021.
two.2) Description
two.2.1) Title
Decision and methodological support services
Lot No
2
two.2.2) Additional CPV code(s)
- 73000000 - Research and development services and related consultancy services
two.2.3) Place of performance
NUTS codes
- UKD - North West (England)
two.2.4) Description of the procurement
Including: providing technical support to evaluation programmes; advanced methodological development for all types of health technologies, including pharmaceuticals, medical and diagnostic technologies and related products; providing educational support; providing advanced methodological, analytical and other ad hoc support to NICE and its independent advisory bodies on the assessment of medicines and medical technologies; providing quality assurance of economic models and other Supplier outputs; providing training on HTA and related disciplines and developing online training resources on HTA for NICE staff and committee members; evidence searching; systematic review and meta-analysis; de-novo modelling.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
33
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
Option to extend for 1 x 15 months periods
two.2.14) Additional information
NICE has had numerous technical issues issuing the notice onto Find a Tender. The notice was published on Contracts Finder on the 15th November 2021.
two.2) Description
two.2.1) Title
Primary data generation and analysis and Real World Evidence Generation for Managed Access
Lot No
3
two.2.2) Additional CPV code(s)
- 73000000 - Research and development services and related consultancy services
two.2.3) Place of performance
NUTS codes
- UKD - North West (England)
two.2.4) Description of the procurement
3a - Primary data generation and analysis
Including: protocol development for promising technologies where the available evidence is insufficient to recommend routine adoption; pragmatic facilitation of collaborative research acting as the academic lead and research sponsor where needed, on clinical, laboratory, and methodological projects investigating the clinical utility of specific healthcare technologies; real-world evidence collection activities including establishing patient registries, analysing register data, and similar schemes; the specification, compilation, validation and analysis of datasets including linkage with other "real-life" data sources. This may include analysis of data protection/ information governance and preparation of paperwork as required. The Supplier may be required to manage a third party to undertake data collection and analysis, developing the contractual paperwork and holding the budget for the work as necessary.
Lot 3b - Real World Evidence Generation for Managed Access
Including: Managed Access evidence generation using existing registers or databases, feasibility studies, data protocol development, pilot studies; data collection and active surveillance; active data surveillance; grant applications; data linkage and complex modelling and/or analyses; register close down; journal publications
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
33
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
option to extend for 1 x 15months periods
two.2.14) Additional information
NICE has had numerous technical issues issuing the notice onto Find a Tender. The notice was published on Contracts Finder on the 15th November 2021.
two.2) Description
two.2.1) Title
Multiple services
Lot No
4
two.2.2) Additional CPV code(s)
- 73000000 - Research and development services and related consultancy services
two.2.3) Place of performance
NUTS codes
- UKD - North West (England)
two.2.4) Description of the procurement
Lot 4a - Clinical and Economic Evidence Assessment - additional capacity
Including: critical appraisal of submitted evidence to support the development of NICE outputs; evidence synthesis; de novo economic modelling and critiquing and revising existing models; updating information and evidence on technologies to support guidance review; preparation of evidence summaries on new and novel technologies; systematic review and meta-analysis; market intelligence analysis; supporting identification, topic selection and scoping of medtech products, confirmations of regulatory status for medtech products.
Lot 4b - Decision and methodological support services - additional capacity
Including: providing technical support to evaluation programmes; advanced methodological development for all types of health technologies, including pharmaceuticals, medical and diagnostic technologies and related products; providing educational support; providing advanced methodological, analytical and other ad hoc support to NICE and its independent advisory bodies on the assessment of medicines and medical technologies; providing quality assurance of economic models and other Supplier outputs; providing training on HTA and related disciplines and developing online training resources on HTA for NICE staff and committee members; evidence searching; systematic review and meta-analysis; de-novo modelling.
Lot 4c - Supplementary services - Research & ethics
Including: advice on research governance and ethics support including access to a research ethics committee.
Lot 4d - Supplementary services - Technical assessment
Including: technical assessment to inform on effective use.
The following sections list the general approach NICE takes to the work carried out by the EACs, followed by details of work packages issued under each Lot and specific details of the modules of work generally included in standard work packages.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
33
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
Option to extend for 1 x 15 months periods
two.2.14) Additional information
NICE has had numerous technical issues issuing the notice onto Find a Tender. The notice was published on Contracts Finder on the 15th November 2021.
Section three. Legal, economic, financial and technical information
three.1) Conditions for participation
three.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
three.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
three.2) Conditions related to the contract
three.2.1) Information about a particular profession
Execution of the service is reserved to a particular profession
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
Framework agreement with several operators
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2021/S 000-009332
four.2.2) Time limit for receipt of tenders or requests to participate
Originally published as:
Date
22 December 2021
Changed to:
Date
30 December 2021
Local time
5:00pm
See the change notice.
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.7) Conditions for opening of tenders
Date
23 December 2021
Local time
11:00am
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: No
six.4) Procedures for review
six.4.1) Review body
National Institute for Health and Care Excellence (NICE)
Level 1 City Tower
Manchester
M14BT
Country
United Kingdom